If the patient meets FDA labeling criteria for a GLP-1 agent (BMI 30, or BMI 27 with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia), the clinician issues a prescription
Endocrinology and metabolism 306 , E13781387, (2014)
$59.99 Save 2.6% when paying via Zelle/Venmo or ACH at checkout 1% of every order supports Childrens Hospital & Disabled American Veterans
these changes showed up by week 3 and held at 2 months
More complex considerations such as potential muscle loss if calorie intake drops too low highlight the importance of medical oversight and individualized nutrition planning
[DOI] [PMC free article] [PubMed] [Google Scholar] 168.Lee S.E., Lee H.Y., Cho H.J., Choe W.S., Kim H., Choi J.O., Jeon E.S., Kim M.S., Hwang K., Chae S.C., et al